The biological relevance of chemokine-proteoglycan interactions.
about
Structural basis of chemokine sequestration by CrmD, a poxvirus-encoded tumor necrosis factor receptorPathophysiology of heparan sulphate: many diseases, few drugsDevelopment, maintenance and disruption of the blood-brain barrierMast cell proteoglycansStructure of mouse IP-10, a chemokineA Model of GAG/MIP-2/CXCR2 Interfaces and Its Functional EffectsRegulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26Identification and characterization of circulating variants of CXCL12 from human plasma: effects on chemotaxis and mobilization of hematopoietic stem and progenitor cells.Proteoglycans in Normal and Healing Skin.Breast cancer: coordinated regulation of CCL2 secretion by intracellular glycosaminoglycans and chemokine motifs.HIV-1 p17 matrix protein interacts with heparan sulfate side chain of CD44v3, syndecan-2, and syndecan-4 proteoglycans expressed on human activated CD4+ T cells affecting tumor necrosis factor alpha and interleukin 2 production.Cysteine Cathepsins Activate ELR Chemokines and Inactivate Non-ELR Chemokines.Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaBCell-specific processing and release of the hormone-like precursor and candidate tumor suppressor gene product, Ecrg4Role of the endothelial surface layer in neutrophil recruitment.Targeting chemokine pathways in esophageal adenocarcinoma.Differential expression of matrix metalloproteinases in the serum of patients with mucopolysaccharidoses.Structural perspectives on antimicrobial chemokines.Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminusRole of heparan sulfate in mediating CXCL8-induced endothelial cell migration.Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivoThe role of chemokines during herpes simplex virus-1 infection.Rational design of novel HIV-1 entry inhibitors by RANTES engineeringTherapeutically targeting protein-glycan interactionsAnti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12.Blood vessels pattern heparan sulfate gradients between their apical and basolateral aspects.Chemokines and chemokine receptors: new insights into cancer-related inflammation.The blood-brain barrier, chemokines and multiple sclerosisStructure-based design of decoy chemokines as a way to explore the pharmacological potential of glycosaminoglycans.In vivo regulation of chemokine activity by post-translational modification.The "in and out" of glucosamine 6-O-sulfation: the 6th sense of heparan sulfate.A general method for site specific fluorescent labeling of recombinant chemokines.Transendothelial migration of effector T cells across inflamed endothelial barriers does not require heparan sulfate proteoglycans.Targeting heparin and heparan sulfate protein interactions.The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial.Selective human endothelial cell activation by chemokines as a guide to cell homing.Perlecan: a major IL-2-binding proteoglycan in murine spleen.Chemokine Signaling and the Regulation of Bidirectional Leukocyte Migration in Interstitial Tissues.Dual specificity of anti-CXCL10-CXCL9 antibodies is governed by structural mimicryNeutralizing nanobodies targeting diverse chemokines effectively inhibit chemokine function
P2860
Q24321225-82240C0E-5941-4909-A56E-0F1BC331D43EQ26823840-E93EFDF1-98DA-49B2-8B52-BE07F61F1126Q26829668-9B65986C-D1C4-492A-B980-5D381733B18BQ27022107-ECCCD070-B437-4D53-B0D2-C3A1D191C043Q27650864-CCF57136-1118-4F03-A0B1-67630752BBDAQ27681101-04F5CF55-5F3E-48DD-A27D-78F6F8C92F07Q28072580-0CE89893-CCCA-4C0C-B195-247DFD502EBCQ33998570-DCAD0246-D3FE-46E3-90EA-7998336D99E0Q34467680-7BDA1772-0AB1-481C-960F-FEB3DC19D95CQ34528303-8C11B9B5-E532-4F03-B137-E6C5FA321107Q35010983-2A20B6E7-F035-4170-9263-58F23EFB5714Q35592746-3762F2E0-3100-4817-BAB9-983266404F5EQ35812229-D4EEADCA-A733-4A20-8C5B-E2908951713DQ36007789-0811E677-D438-40B2-9AB0-5593C021EEEFQ36057934-4376D64D-B9FE-4709-BB15-E5EBCA202AA6Q36187424-C6B3AF19-2A42-4B0E-AD88-7C800248FB6FQ36433328-04AE5656-596D-42D5-86ED-C8DDB45A2C37Q36492362-2D84B1AE-2538-42FC-99CB-A1A9421F3C80Q36508793-CF8667CB-BAF2-4198-86B8-1F759F4512DDQ36566289-50737088-F571-45BC-8718-06C7F8C53AC6Q36611135-03C745BB-2AF1-4E80-9090-5E5A9376978DQ36726766-4566B5E9-63CA-48A5-8CFE-F0C27AE253AEQ36793736-DCED05CB-1875-45A5-BD55-B7067E5B442CQ37445949-486002AE-EFC1-4586-9293-8C8E7E32F95CQ37470294-2AC9DAC3-0E97-4025-8961-D30A5CBC05B2Q37505173-25EC2AE5-1880-47A9-834C-7D769D99BAB3Q37694068-C6425596-B890-4DDB-9B1F-6BB66AF92225Q37778548-38CBF787-8CA2-4492-BF63-82EA6A7D224EQ38022773-948150F8-6797-495F-88E8-B989FAAB8623Q38102877-67168485-C70D-4CD8-BB07-02B88F5B0096Q38290246-C7CDF763-EAC6-4465-99C9-9C9C41C621D1Q39027877-43A16267-74F4-46FC-B577-9AB4DA6203D6Q39036330-BB7D5E51-70B8-4096-A6E7-8408D1A13BEAQ39399937-3FE38CDA-978A-4D95-B18C-553BDB1C6C2EQ39686490-B2E76C9D-0FAA-464D-AD2E-BF6DAC463E7BQ39938539-1BAB0C60-BA87-4FA0-ABED-ACAF3DE9B8FCQ40044234-D7BF595E-EFF2-4346-A458-78243EA37419Q40200891-AF7AB77D-0FAA-43EE-AE95-B87D70724CCBQ40353620-E8A2A074-F52C-47A1-B136-A7E2B9E3EAB0Q41861205-D7428E2A-8226-45A3-8360-472A4A64649F
P2860
The biological relevance of chemokine-proteoglycan interactions.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The biological relevance of chemokine-proteoglycan interactions.
@ast
The biological relevance of chemokine-proteoglycan interactions.
@en
type
label
The biological relevance of chemokine-proteoglycan interactions.
@ast
The biological relevance of chemokine-proteoglycan interactions.
@en
prefLabel
The biological relevance of chemokine-proteoglycan interactions.
@ast
The biological relevance of chemokine-proteoglycan interactions.
@en
P356
P1476
The biological relevance of chemokine-proteoglycan interactions.
@en
P2093
Proudfoot AE
P304
P356
10.1042/BST0340422
P577
2006-06-01T00:00:00Z